Dishman Pharmaceuticals and Chemicals Ltd Merged Annually Results

Gross Sales

1,633.86

1,561.85

1,560.35

1,373.23

1,267.56

Excise Duty

0

0

0

0

0

Net Sales

1,633.86

1,561.85

1,560.35

1,373.23

1,267.56

Other Operating Income

79.83

34.2

28.39

12.07

4.65

Other Income

26.13

26.54

86.91

24.87

17.78

Total Income

1,739.82

1,622.59

1,675.65

1,410.19

1,290

Total Expenditure

1,261.23

1,185.71

1,276.03

1,053.2

980.46

PBIDT

478.59

436.88

399.62

356.98

309.54

Interest

49.01

94.44

89.71

92.05

80.45

PBDT

429.58

342.44

309.91

264.92

229.08

Depreciation

213.5

109.08

150.71

108.55

83.83

Minority Interest Before NP

0

0

0

0

0

Tax

47.89

62.35

39.44

47.13

44.99

Deferred Tax

22.76

0

0

0

0

Reported Profit After Tax

145.43

171.01

119.76

109.23

100.25

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

145.43

171.12

119.81

109.26

100.29

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

145.43

171.12

119.81

109.26

100.29

EPS (Unit Curr.)

9.01

21.2

14.84

13.53

12.42

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

100

100

60

60

Equity

0

16.14

16.14

16.13

16.13

Public Shareholding (Number)

0

0

3,11,48,687

3,11,11,336

3,11,76,816

Public Shareholding (%)

0

0

38.6

38.54

38.63

Pledged/Encumbered - No. of Shares

0

0

1,50,16,500

1,58,75,421

87,75,000

Pledged/Encumbered - % in Total Promoters Holding

0

0

30.31

32.02

17.71

Pledged/Encumbered - % in Total Equity

0

0

18.61

19.67

10.86

Non Encumbered - No. of Shares

0

0

3,45,31,949

3,37,10,376

4,07,45,320

Non Encumbered - % in Total Promoters Holding

0

0

69.69

67.98

82.27

Non Encumbered - % in Total Equity

0

0

42.79

41.77

50.49

PBIDTM(%)

29.29

27.97

25.61

25.99

24.41

PBDTM(%)

26.29

21.92

19.86

19.29

18.07

PATM(%)

8.9

10.94

7.67

7.95

7.9